Jinhao Medical shareholder Jintongsheng reduces holdings by 499.9k shares, cashing out 8.8025 million yuan

On April 7, 2026, Huizhou Jinhui Medical Technology Co., Ltd. (hereinafter referred to as “Jinhui Medical”) issued an announcement on the reduction of shares by shareholders, disclosing that the plan for one of the company’s actual controllers and concerted actors, Huizhou Jintongsheng Investment Partnership (Limited Partnership) (hereinafter referred to as “Jintongsheng”), has been completed. After this reduction, Jintongsheng’s shareholding ratio decreased from 2.4854% to 1.9776%.

Subject of the reduction and background of the plan

The announcement shows that the subject of the reduction, Jintongsheng, is a concerted actor of Jinhui Medical’s actual controller, and its shares were obtained before the company was listed on the Beijing Stock Exchange. Prior to the implementation of this reduction plan, Jintongsheng held 2.45M shares of the company, accounting for 2.4854% of the total share capital.

Details of the reduction implementation

According to the announcement, Jintongsheng carried out the reduction through centralized bidding transactions. The specific reduction details are as follows:

The above data shows that between March 2, 2026, and April 3, 2026, Jintongsheng reduced a total of 499,906 shares of the company at prices ranging from 16.32 yuan/share to 21.38 yuan/share, accounting for 0.5077% of the company’s total share capital, with a total reduction amount of approximately 8.8025 million yuan. As of the disclosure date of this announcement, the reduction plan has been completed, with no early termination or unimplemented cases.

Shareholding status after the reduction

After this reduction, Jintongsheng still holds 1,947,200 shares of Jinhui Medical, with a shareholding ratio of 1.9776%, remaining a concerted actor of the company’s actual controllers.

The announcement also states that the above reduction actions comply with the “Company Law of the People’s Republic of China,” the “Securities Law of the People’s Republic of China,” and relevant regulations of the Beijing Stock Exchange. The relevant shareholders have issued a “Share Reduction Result Notification Letter,” which will serve as a reference document for investors.

Disclaimer: The market carries risks; investment should be cautious. This article is automatically published by an AI large model based on third-party databases and does not represent Sina Finance’s views. All information appearing in this article is for reference only and does not constitute personal investment advice. Please refer to the actual announcement for any discrepancies. If you have questions, please contact biz@staff.sina.com.cn.

Click to view the original announcement>>

Massive information, precise interpretation, all on Sina Finance APP

Editor: Xiao Lang Express